Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Region, 2018-2027 (USD Billion)
1.2.2. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product, 2018-2027 (USD Billion)
1.2.3. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application, 2018-2027 (USD Billion)
1.2.5. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Dynamics
3.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product
5.1. Market Snapshot
5.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Product, Performance - Potential Analysis
5.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Reagent
5.4.3. Services
Chapter 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology
6.1. Market Snapshot
6.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Technology, Performance - Potential Analysis
6.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
6.4.1. Immunoassay
6.4.2. Molecular Diagnostics
6.4.3. Microbiology
6.4.4. Others
Chapter 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application
7.1. Market Snapshot
7.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Application, Performance - Potential Analysis
7.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
7.4.1. Streptococcus
7.4.2. Clostridium Difficile
7.4.3. Carbapenem-resistant enterobacterial testing (CRE)
7.4.4. Respiratory virus
7.4.5. Tuberculosis (TB) & drug-resistant TB
7.4.6. Human Immunodeficiency Virus (HIV)
7.4.7. Gonorrhea
7.4.8. Chlamydia
7.4.9. Others
Chapter 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use
8.1. Market Snapshot
8.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by End-Use - Potential Analysis
8.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
8.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis
8.4.1. Point of Care
8.4.2. Central Laboratories
8.4.3. Others
Chapter 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Analysis
9.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Market Snapshot
9.2. North America Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.2.1. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-Use breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3. Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.3.1. U.K. Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.2. Germany Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.3. France Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.4. Spain Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.5. Italy Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.3.6. Rest of Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4. Asia-Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.4.1. China Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.2. India Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.3. Japan Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.4. Australia Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.5. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.4.6. Rest of Asia Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.5. Latin America Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot
9.5.1. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.5.2. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) Market
9.6. Rest of The World Infectious Diseases in-Vitro Diagnostics (IVD) Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Becton, Dickinson and Company
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. BioMrieux SA
10.2.3. Abbott Laboratories
10.2.4. Quidel Corporation
10.2.5. OraSure Technologies, Inc.
10.2.6. Hologic Inc. (Gen Probe)
10.2.7. Qiagen
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. Siemens Healthcare GmbH
10.2.10. Bio-Rad Laboratories, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption